| Detected | Trial | Change |
|---|---|---|
| 2026-06-12 | NCT05280457 HPV 16-positive and/or HPV 18-positive Recurrent and/or For Patients With Metastatic Head… |
overall status: "Recruiting" → "Active Not Recruiting" |
| 2026-06-12 | NCT05280457 HPV 16-positive and/or HPV 18-positive Recurrent and/or For Patients With Metastatic Head… |
date change Primary completion pushed: 2026-03 -> 2027-01 |
| 2026-06-12 | NCT05280457 HPV 16-positive and/or HPV 18-positive Recurrent and/or For Patients With Metastatic Head… |
date change Completion pushed: 2026-03 -> 2027-01 |
| 2026-06-11 | NCT04603248 A Study for Identification of Immune Determinants for Response to Nivolumab in Recurrent… |
Trial completed |
| 2026-06-11 | NCT04603248 A Study for Identification of Immune Determinants for Response to Nivolumab in Recurrent… |
date change Primary completion moved earlier: 2026-09 -> 2026-03-18 |
| 2026-06-11 | NCT04603248 A Study for Identification of Immune Determinants for Response to Nivolumab in Recurrent… |
date change Completion moved earlier: 2026-09 -> 2026-03-18 |
| 2026-05-23 | NCT07367893 Exercise Echocardiography Registry for Ischemic and Non-Ischemic Heart Disease |
Recruitment opened |
| First Posted | Trial | Phase | Status |
|---|---|---|---|
| 2026-06-11 | NCT07640932 Lurbinectedin Plus Paclitaxel Versus Paclitaxel in Patients With Previously Treated Small… | Phase 2 | Not Yet Recruiting |
| 2026-06-03 | NCT07622485 In-Hospital Wearable-Based Monitoring Versus Standard Care in Cardiovascular Disease… | Not Yet Recruiting | |
| 2026-06-03 | NCT07622498 The Purpose of This Clinical Trial is to Evaluate the Accuracy of Blood Pressure… | Recruiting | |
| 2026-06-02 | NCT07619950 EVERolimus and LenvAtinib Versus Everolimus for Bone Sarcoma | Phase 2 | Not Yet Recruiting |
| NCT ID | Title | Condition | Status |
|---|---|---|---|
| Phase 4 | |||
| NCT07471867 | Effect of ZaStaprazan on Platelet Reactivity of Clopidogrel After PercuTaneous CoronAry… | Chronic Coronary Syndrome | Recruiting |
| NCT06528262 | Effect of Enavogliflozin on Recurrence of Atrial Fibrillation After Catheter Ablation | Atrial Fibrillation | Recruiting |
| NCT07467174 | RCT Comparing Reduced-port Robotic and Conventional Laparoscopic Subtotal Gastrectomy | Gastric Cancer | Not Yet Recruiting |
| NCT05361421 | Effect of Intensive LDL-cholesterol Targeting for Elderly Patients With Cardiovascular… | Cardiovascular Disease | Active, Not Recruiting |
| Phase 3 | |||
| NCT06677970 | Outcome in Patients Treated With Endovascular Thrombectomy - optIMAL Blood Pressure… | Acute Ischemic Stroke | Recruiting |
| Phase 2 | |||
| NCT04910347 | Consolidation Nivolumab After Concurrent Chemoradiotherapy in Locally Advanced… | Locally Advanced Nasopharyngeal Carcinoma | Recruiting |
| NCT06268210 | Neoadjuvant Lazertinib With or Without Chemotherapy for Patients With EGFR-mutated… | Non-small Cell Lung Cancer | Recruiting |
| NCT07469683 | An Open-label, Randomized Phase 2 Clinical Trial to Evaluate the Efficacy and Safety of… | Clear Cell Renal Cell Carcinoma | Recruiting |
| NCT07340164 | Trastzumab Deruxtecan Versus SOC in Recurrent Ovarian That Progressed on Prior PARP… | Ovarian Cancer | Recruiting |
| NCT04605770 | Pemetrexed, Cisplatin With Soft Tissue Sarcoma | Sarcoma,Soft Tissue | Recruiting |
| NCT06023862 | A Three-arm Randomized Phase II Study of Dostarlimab Alone or With Bevacizumab Versus… | Ovarian Neoplasms | Recruiting |
| NCT05206812 | Window of Opportunity Trial of Durvalumab (MEDI4736) to Identify Immune Dynamics in… | Non Small Cell Lung Cancer | Active, Not Recruiting |
| NCT05786430 | Lazertinib+Pemetrexed/Carboplatin in Patients With EGFR Sensitizing Mutation Positive… | Non-small Cell Lung Cancer | Active, Not Recruiting |
| NCT05286060 | Trial of the Combination of GX-188E Vaccination, GX-I7 and Pembrolizumab in Patients With… | Head and Neck Squamous Cell Carcinoma | Active, Not Recruiting |
| NCT06250777 | Efficacy and Safety of T-DXd in HER2-mutant Advanced Lung Cancer Patients With… | Non Small Cell Lung Cancer | Enrolling by Invitation |
| NCT07477548 | A Study to Evaluate the Efficacy and Safety of Everolimus in Patients With… | Vascular Malformations | Not Yet Recruiting |
| NCT07507188 | Collaborative Clinical-translational Cohort of Amivantamab Plus Lazertinib and… | Non Small Cell Lung Cancer | Not Yet Recruiting |
| NCT07547592 | Gemcitabine and Docetaxel With or Without Bevacizumab (Onbevzi) for Soft Tissue Sarcoma | Neoplasms of Connective and Soft Tissue With an Unspecified Anatomical Site | Not Yet Recruiting |
| NCT07619950 | EVERolimus and LenvAtinib Versus Everolimus for Bone Sarcoma | Neoplasms of Bone and Articular Cartilage With Unspecified Anatomical Site | Not Yet Recruiting |
| NCT05280457 | HPV 16-positive and/or HPV 18-positive Recurrent and/or For Patients With Metastatic Head… | Head and Neck Squamous Cell Carcinoma | Active, Not Recruiting |
| NCT07640932 | Lurbinectedin Plus Paclitaxel Versus Paclitaxel in Patients With Previously Treated Small… | Carcinoma, Small Cell Lung | Not Yet Recruiting |
| Phase 1/2 | |||
| NCT03694236 | Concurrent Neoadjuvant Chemoradiotherapy Plus Durvalumab (MEDI4736) in Resectable Stage… | Potentially Resectable Stage II/IIIa NSCLC | Recruiting |
| Phase 1 | |||
| NCT07333820 | Clinical Study to Evaluate the Safety and Anti-Tumor Activity of AB-201 | Malignant Neoplasm of Stomach, Unspecified | Not Yet Recruiting |
| NCT07495293 | Ultra-hypofractionated Carbon-ion Therapy for Prostate Cancer | Prostate Cancer | Not Yet Recruiting |
| Not specified | |||
| NCT05585411 | PReventive Effect Of Left Bundle Branch Area Pacing Versus righT vEntricular paCing on… | Bradyarrhythmia | Recruiting |